TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now October 11, 1996
